Company profile · Biotech & medical
Formosa Laboratories
台耀化學股份有限公司 · 4746
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Formosa Laboratories develops and manufactures active pharmaceutical ingredients (APIs) and injectables.[1]
The company provides contract development and manufacturing organization (CDMO) services, including API process development, impurity identification and synthesis, antibody-drug conjugates (ADCs) manufacturing, injectable manufacturing, fermentation, and peptide synthesis.[1]
Its manufacturing facilities cover APIs, high potency APIs (HPAPIs), antibody-drug conjugates, and injectables, operating from pilot plant to kilogram and ton scales.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$498m | +24.0% | +1.7% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$1m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Formosa Laboratories, Inc. |
|---|---|
| Chinese name | 台耀化學股份有限公司 |
| Stock code | 4746 (TWSE) |
| Industry | Biotech & medical |
| Founded | 29 Dec 1995 |
| Listed | 01 Mar 2011 |
| Paid-in capital | NT$1.2bn |
| Chairman | 程正禹 |
| President | 程正禹 |
| Headquarters | 36 Heping St., Luzhu Dist. Taoyuan 338002, Taiwan |
| Website | https://www.formosalab.com |
| Official business description | 原料藥 · 委託研發代工 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- Formosa Laboratories · website · retrieved 03 Nov 2026
- About us - Formosa Laboratories, Inc. · website · retrieved 03 Nov 2026
Using it at work? Join the team-plan waiting list